Showing results (71-80 of 157) with videos related to

Sort By:
Pageof 16
Journal of Affective Disorders|December 18, 2023
Evaluation of a novel instrument for detecting bipolar disorders in China: The Rapid Mood Screener (RMS)Yuhua Liao, Xue Han, Lan Guo, et al.
Journal of Affective Disorders|February 14, 2026
Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depressionErica S Kaczmarek, Nelson B Rodrigues, Noah Chisamore, et al.
Neuropharmacology|November 6, 2022
The therapeutic role of ketamine and esketamine in treating psychopathological domains of depressionMuhammad Youshay Jawad, Joshua D Di Vincenzo, Sebastian Badulescu, et al.
Therapeutic Advances in Psychopharmacology|December 25, 2025
Effects of glucagon-like peptide-1 receptor agonists on psychiatric disorders: a systematic reviewSerene Lee, Liyang Yin, Kayla M Teopiz, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 6, 2024
Impact of vortioxetine on psychosocial functioning moderated by symptoms of fatigue in post-COVID-19 condition: a secondary analysisSebastian Badulescu, Gia Han Le, Sabrina Wong, et al.
Expert Opinion on Therapeutic Targets|April 29, 2025
The sigma-1 receptor: a mechanistically-informed therapeutic target for antidepressantsNaomi Xiao, Liyang Yin, Kayla M Teopiz, et al.
Journal of Affective Disorders|January 20, 2024
A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic reviewSabrina Wong, Angela T H Kwan, Kayla M Teopiz, et al.
Journal of Affective Disorders|January 16, 2025
Hepatic adverse events associated with ketamine and esketamine: A population-based disproportionality analysisAngela T H Kwan, Moiz Lakhani, Kayla M Teopiz, et al.
Pageof 16